Who owns KEZAR LIFE SCIENCES INC?
- Ticker: KZR
- CUSIP Number: 49372l209
Tip: Access positions for across all investors
Analyze quarterly positions in Kezar Life Sciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Kezar Life Sciences stock
Who bought or sold KEZAR LIFE SCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BML Capital Management | 721k | $2.8M | 13% | Sep 2025 |
|
| Tang Capital Management | 720k | $2.8M | 0% | Sep 2025 |
|
| Suvretta Capital Management | 717k | $2.8M | 0% | Sep 2025 |
|
| Stonepine Capital Management | 383k | $1.5M | 126% | Sep 2025 |
|
| Vanguard Group | 268k | $1.0M | -3% | Sep 2025 |
|
| OrbiMed Advisors | 193k | $752k | 0% | Sep 2025 |
|
| Acadian Asset Management | 134k | $519k | 0% | Sep 2025 |
|
| Peapod Lane Capital | 126k | $491k | 9% | Sep 2025 |
|
| ADAR1 Capital Management | 125k | $487k | -15% | Sep 2025 |
|
| Renaissance Technologies | 116k | $452k | 33% | Sep 2025 |
|
| Ikarian Capital | 107k | $417k | 0% | Sep 2025 |
|
| BlackRock | 98k | $383k | 0% | Sep 2025 |
|
| Qiming U.S. Ventures Management | 83k | $323k | 0% | Sep 2025 |
|
| Shay Capital | 68k | $264k | 0% | Sep 2025 |
|
| Geode Capital Management | 66k | $256k | 1% | Sep 2025 |
|
| Two Sigma Advisers | 54k | $212k | -1% | Sep 2025 |
|
| Bridgeway Capital Management | 41k | $160k | 0% | Sep 2025 |
|
| Citadel Advisors | 34k | $132k | 100% | Sep 2025 |
|
| Rbf Capital | 28k | $110k | 0% | Sep 2025 |
|
| Two Sigma Investments | 24k | $92k | -5% | Sep 2025 |
|
| Dimensional Fund Advisors | 23k | $91k | -22% | Sep 2025 |
|
| State Street Corporation | 21k | $82k | 0% | Sep 2025 |
|
| Boothbay Fund Management | 21k | $82k | 0% | Sep 2025 |
|
| Northern Trust | 14k | $54k | 0% | Sep 2025 |
|
| Landscape Capital Management | 13k | $51k | 100% | Sep 2025 |
|
| FMR | 8.7k | $34k | -61% | Sep 2025 |
|
| Morgan Stanley | 8.7k | $44k | 100% | Jun 2025 |
|
| Wells Fargo & Company | 5.8k | $23k | 2% | Sep 2025 |
|
| Tower Research Capital | 1.2k | $4.6k | 719% | Sep 2025 |
|
| Global Retirement Partners | 1.0k | $3.9k | 0% | Sep 2025 |
|
| UBS Group | 356.00 | $1.4k | 768% | Sep 2025 |
|
| Jpmorgan Chase & Co | 209.00 | $814.995500 | 26% | Sep 2025 |
|
| Atlantic Trust | 100.00 | $390.000000 | 0% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 96.00 | $373.996800 | 0% | Sep 2025 |
|
| Advisor Group Holdings | 90.00 | $323.001000 | 0% | Sep 2025 |
|
| Barclays | 1.00 | $4.000000 | 0% | Sep 2025 |
|
Who sold out of Kezar Life Sciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Avidity Partners Management | Jun 2025 | 503k | $2.3M |
| Sphera Funds Management | Jun 2025 | 59k | $268k |
| Goldman Sachs Group | Mar 2025 | 28k | $138k |
| Millennium Management | Jun 2025 | 26k | $118k |
| Simplex Trading | Jun 2025 | 43.00 | $0 |